Vor Biopharma
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
ATTAR EYAL C. officer: CHIEF MEDICAL OFFICER
 Common Stock 14,645 $1.39 $20,357
Sale
5AM VENTURES VI, L.P. 10 percent owner
 Common Stock 330,706 $15.3 $5,059,802
Sale
PARMAR KUSH director, 10 percent owner
 Common Stock 330,706 $15.3 $5,059,802
Option
CHAKRABORTY TIRTHA officer: Chief Scientific Officer
 Common Stock 17,446 $1.36 $23,727
Option
CHAKRABORTY TIRTHA officer: Chief Scientific Officer
 Employee Stock Option (right to buy) 17,446 $1.36 $23,727
Purchase
RA CAPITAL MANAGEMENT, L.P. director, 10 percent owner
 Common Stock 2,979,566 $18 $53,632,188
Purchase
PARMAR KUSH director, 10 percent owner
 Common Stock 555,555 N/A N/A
Purchase
5AM VENTURES VI, L.P. 10 percent owner
 Common Stock 555,555 $18 $9,999,990

Showing 1 to 8 of 8 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: